0001209191-21-033810.txt : 20210518
0001209191-21-033810.hdr.sgml : 20210518
20210518201558
ACCESSION NUMBER: 0001209191-21-033810
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210518
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SEIDENBERG BETH C
CENTRAL INDEX KEY: 0001184592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 21938037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
STREET 2: 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
STREET 2: 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-18
0
0001831828
Vera Therapeutics, Inc.
VERA
0001184592
SEIDENBERG BETH C
C/O VERA THERAPEUTICS, INC.
170 HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Class A Common Stock
2021-05-18
4
C
0
423642
A
423642
I
See footnote
Class A Common Stock
2021-05-18
4
C
0
100526
A
524168
I
See footnote
Class A Common Stock
2021-05-18
4
C
0
818984
A
1343152
I
See footnote
Series A Preferred Stock
2021-05-18
4
C
0
423642
0.00
D
Class A Common Stock
423642
0
I
See footnote
Series B Preferred Stock
2021-05-18
4
C
0
100526
0.00
D
Class A Common Stock
100526
0
I
See footnote
Series C Preferred Stock
2021-05-18
4
C
0
818984
0.00
D
Class A Common Stock
818984
0
I
See footnote
The Series A Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
Consists of 409,620 shares of Class A Common Stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 14,022 shares of Class A Common Stock held by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
The Series B Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
Consists of 506,819 shares of Class A Common Stock held by KPCB XVI and 17,349 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
Consists of 1,298,695 shares of Class A Common Stock held by KPCB XVI and 44,457 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
Consisted of 409,620 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by KPCB XVI and 14,022 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by XVI Founders.
Consisted of 97,199 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by KPCB XVI and 3,327 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by XVI Founders.
Consisted of 791,876 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by KPCB XVI and 27,108 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by XVI Founders.
/s/ Joseph R. Young, Attorney-in-Fact
2021-05-18